Newsroom

Sorted by: Latest

-

Resumen: Hitachi amplía HMAX para acelerar la implementación de la IA física

TOKIO--(BUSINESS WIRE)--Hitachi, Ltd. («Hitachi») ha anunciado hoy la ampliación de HMAX by Hitachi («HMAX»)*, un conjunto de soluciones de última generación que aporta el potencial de la IA a las infraestructuras sociales. La cartera de HMAX se compone de soluciones específicas para cada sector, adaptadas a las distintas industrias y operaciones empresariales, así como de un conjunto de soluciones de base que abarcan distintos ámbitos. Como parte de esta ampliación, se ha incorporado HMAX Data...
-

Sexual Health Is Health: Testing, Treatment and Prevention for All, says AHF

LOS ANGELES--(BUSINESS WIRE)--As sexually transmitted infections continue to rise worldwide, AIDS Healthcare Foundation (AHF) marks World Sexual Health Day by calling on governments and health systems to expand access to prevention, testing, and treatment services for HIV and other STIs. Despite proven tools to prevent, diagnose, and treat HIV and other STIs, gaps in access continue to put millions of people at risk globally. With an estimated 1.2 million new HIV infections each year globally,...
-

Robbins LLP Informs Investors of the Unicycive Therapeutics, Inc. Securities Class Action

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP is Investigating Allegations that Unicycive Therapeutics, Inc. Failed to Clean Up Deficiencies at its Vendor's Manufacturing Facility...
-

Silicon Motion Reaches Initial Milestone in EU Cyber Resilience Act Compliance Program

TAIPEI, Taiwan & MILPITAS, Calif.--(BUSINESS WIRE)--Silicon Motion Technology Corporation (NasdaqGS: SIMO), a global leader in designing and marketing NAND flash controllers for solid-state storage devices, today announced that it has completed the first stage of its compliance program for the European Union Cyber Resilience Act (CRA). Following a comprehensive internal assessment, the company has aligned its product cybersecurity controls and processes with the CRA’s incident-reporting obligat...
-

Roland Marks Ten Years Since The Future. Redefined. with Then. Now. Next. Anniversary Campaign

LOS ANGELES--(BUSINESS WIRE)--Ten years after The Future. Redefined., its landmark 909 Day livestream that introduced more than 30 new products to musicians worldwide, Roland is celebrating the milestone with a global anniversary campaign that looks back on a decade of innovation while showcasing what's next. Built around the theme Then. Now. Next., the campaign connects the legacy of the 2016 event to today’s latest products, customer experiences, and future-focused initiatives spanning Roland...
-

proteanTecsとメガチップス、次世代LSI設計向け健全性・性能管理ソリューションで協業

イスラエル・ハイファ--(BUSINESS WIRE)--(ビジネスワイヤ) -- 先端エレクトロニクス向け健全性・性能管理ソリューションのリーディングカンパニーであるproteanTecs®は本日、メガチップスの次世代ASICおよびLSIデジタルシステムに、proteanTecsの組み込み型モニタリング技術を統合するため、同社と協業することを発表しました。 両社の協業では、AIや高性能電子システムに使用される先進的なASICおよびLSI設計を対象に、開発、製造から市場投入後の実運用まで、シリコン内部の状態を詳細に可視化することに取り組みます。 proteanTecsのオンチップ・モニタリング・ソリューションとソフトウェア・アプリケーションにより、メガチップスの顧客は、開発段階から製品導入後まで、具体的な対策につなげられるシリコン内部の知見を得られるようになります。これにより、製品立ち上げの迅速化、高度な電力・性能管理、信頼性の向上に加え、市場投入後の安定した動作とその予測性の向上を実現します。今回の協業には、実際のワークロードに応じて消費電力を動的に削減するproteanTecsの...
-

YSS INVESTOR ALERT: York Space Systems Inc. Investors with Substantial Losses Have Opportunity to Lead the York Space Class Action Lawsuit, Robbins Geller Rudman & Dowd LLP Announces

SAN DIEGO--(BUSINESS WIRE)--The York Space Class Action Lawsuit alleges York Space and its top executives made false and/or misleading statements to investors....
-

UNCY CLASS ACTION NOTICE: Glancy Prongay Wolke & Rotter LLP Files Securities Fraud Lawsuit On Behalf Of Unicycive Therapeutics, Inc. Investors

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay Wolke & Rotter LLP (“GPWR”), announces that it has filed a class action lawsuit in the United States District Court for the Northern District of California, captioned Patel v. Unicycive Therapeutics, Inc. et al., Case No. 25-cv-09559, on behalf of persons and entities that purchased or otherwise acquired Unicycive Therapeutics, Inc. (“Unicycive” or the “Company”) (NASDAQ: UNCY) securities between December 29, 2025 and June 29, 2026, inclusive (th...
-

ZANVASTRO™ (zilganersen) approved by the FDA as the first and only disease modifying treatment for Alexander disease (AxD) in pediatric and adult patients

CARLSBAD, Calif.--(BUSINESS WIRE)--Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that the U.S. Food and Drug Administration (FDA) has approved ZANVASTRO™ (zilganersen) for the treatment of Alexander disease (AxD) in pediatric and adult patients. ZANVASTRO is the first and only disease modifying treatment for AxD, an ultra-rare, progressive and often fatal neurological disorder that can affect motor, cognitive, autonomic and gastrointestinal function. Until now, treatment of AxD has...
-

KBRA Assigns AAA Rating to State of Wisconsin General Obligation Bonds of 2026, Series B

NEW YORK--(BUSINESS WIRE)--KBRA assigns a long-term rating of AAA with a Stable Outlook to the State of Wisconsin General Obligation Bonds of 2026, Series B. Proceeds will be deposited in the State's Capital Improvement Fund and will be spent as the State incurs costs for various borrowing or issuance purposes. Key Credit Considerations The rating actions reflect the following key credit considerations: Credit Positives Strength and breadth of the G.O. pledge, coupled with liquidity and market...